Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development tracks for cancer prevention markers.

Stuart G Baker1, Barnett S Kramer, Philip C Prorok

  • 1Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892-7354, USA. sb16i@nih.gov

Disease Markers
|August 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate cancer screening: Decision-making when MRI results are inconclusive for cancer (PI-RADS 3).

Urologic oncology·2026
Same author

Adjusting for non-compliance and contamination with a more plausible assumption.

Journal of medical screening·2026
Same author

Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102).

Journal of the National Cancer Institute·2026
Same author

The efficient stored specimen design for evaluating multiple screening technologies: Application to multicancer detection tests.

Journal of medical screening·2025
Same author

Minimum test tradeoff applied to uterine artery pulsatility index for antepartum prediction of preeclampsia.

Pregnancy hypertension·2025
Same author

Cohort Profile: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

International journal of epidemiology·2025

This study outlines a framework for using biomarkers in cancer prevention research, detailing their roles in early detection, as surrogate endpoints, and for identifying cohorts for primary prevention strategies.

Area of Science:

  • Oncology
  • Biomarker Research
  • Cancer Prevention

Background:

  • Biomarkers play a crucial role in advancing cancer prevention research.
  • Understanding the diverse applications of biomarkers is essential for effective cancer control strategies.

Purpose of the Study:

  • To establish a general framework for the application of biomarkers in cancer prevention.
  • To delineate the specific roles of biomarkers, including early detection, surrogate endpoints, and cohort identification for primary prevention.
  • To describe the distinct phases involved in the evaluation of biomarkers for cancer prevention.

Main Methods:

  • Conceptual framework development.
  • Literature review of biomarker applications in cancer prevention research.
  • Synthesis of existing knowledge on biomarker evaluation phases.

Related Experiment Videos

Main Results:

  • A comprehensive framework is presented, categorizing biomarker roles in cancer prevention.
  • Key roles identified: early detection, surrogate endpoint, and cohort identification for primary prevention.
  • A phased approach for biomarker evaluation is described.

Conclusions:

  • The proposed framework provides a structured approach to biomarker utilization in cancer prevention.
  • Standardizing biomarker roles and evaluation phases can accelerate the development of effective prevention strategies.
  • This framework supports the integration of biomarkers into diverse cancer prevention research settings.